P

PDEX

PDEX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
PDEX Live QuoteReal-time
$63.49
+$2.93(+4.84%)1M
Day Range$61.01 – $64.35
Open$64.35
Previous Close$63.94
Volume37.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$204.61M
P/E Ratio (TTM)17.6
Forward P/E20.7
EPS (TTM)$3.63
Price to Book4.1
Dividend Yield0.65%
Beta (Volatility)0.10
IndustryMEDICAL INSTRUMENTS & SUPPLIES
52-Week RangeCurrent: $63.49 (70%)
Low: $32.14High: $77.00
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$80.00-46.7% upside

Insider Buys

0

$0

Insider Sales

21

$6.25M

Total Volume

$6.25M

41 transactions

Net Activity

$6.25M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Cabillot Raymond E

Dir, 10%

0 buys14 sells

$4.18M total

V
2

Van Kirk Richard Lee Jr

CEO

0 buys3 sells

$1.84M total

C
3

Charlton Alisha

CFO

0 buys2 sells

$181K total

D
4

Domingo Angelita Rebamontan

Dir

0 buys1 sells

$47K total

M
5

Multiple Insiders

S - Sale Insiders

0 buys20 sells

$0 total

Trading History
PDEX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 11, 2026

2 months ago

Van Kirk Richard Lee Jr

CEO

CEO
Sell765$59.36$45K

Sep 11, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell79.2K$-765.00$0

Sep 9, 2026

2 months ago

Charlton Alisha

CFO

CFO
Sell2.3K$61.30$141K

Sep 9, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell80.0K$-19235.00$0

Sep 9, 2026

2 months ago

Van Kirk Richard Lee Jr

CEO

CEO
Sell19.2K$60.58$1.17M

Mar 16, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell18.8K$-998.00$0

Mar 16, 2026

8 months ago

Domingo Angelita Rebamontan

Dir

Director
Sell998$47.24$47K

May 21, 2026

6 months ago

Van Kirk Richard Lee Jr

CEO

CEO
Sell10.0K$62.62$626K

May 21, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell89.7K$-10000.00$0

Apr 2, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.02M$-4526.00$0

Apr 2, 2025

19 months ago

Swenson Nicholas John

Dir, 10%

Director
Sell4.5K$0.00$0

Apr 1, 2025

19 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell270.8K$-7263.00$0

Apr 1, 2025

19 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell7.3K$50.01$363K

Mar 28, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell278.1K$-1678.00$0

Mar 28, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell1.7K$50.00$84K

Mar 26, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell279.8K$-3096.00$0

Mar 26, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell3.1K$50.13$155K

Mar 24, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell282.9K$-15711.00$0

Mar 24, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell15.7K$50.23$789K

Mar 19, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell2.1K$50.00$105K

Mar 19, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell298.6K$-2101.00$0

Mar 14, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell5.2K$50.00$258K

Mar 14, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell300.7K$-5151.00$0

Mar 10, 2025

20 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell12.8K$45.02$577K

Mar 10, 2025

20 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell305.8K$-12806.00$0

Jan 30, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell318.7K$-1100.00$0

Jan 30, 2025

21 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell1.1K$45.01$50K

Jan 27, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell319.8K$-13458.00$0

Jan 27, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell13.5K$41.63$560K

Jan 23, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell2.3K$41.65$95K

Jan 23, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell333.2K$-2271.00$0

Jan 21, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell345.5K$-9202.00$0

Jan 21, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell9.2K$44.55$410K

Jan 16, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell8.3K$44.75$372K

Jan 16, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell344.7K$-8313.00$0

Jan 14, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell3.0K$45.18$137K

Jan 14, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell353.0K$-3026.00$0

Jan 10, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell356.0K$-4824.00$0

Jan 10, 2025

22 months ago

Cabillot Raymond E

Dir, 10%

Director
Sell4.8K$46.93$226K

Nov 7, 2024

24 months ago

Charlton Alisha

CFO

CFO
Sell1.0K$40.02$40K

Nov 7, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell15.3K$-1000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
PDEX Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

PDEX has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for PDEX

Over the last 90 days, corporate insiders at PDEX (PDEX) engaged in a total of 41 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 21 were sales. The total volume of insider trading reached $6.25M.

The net insider activity for PDEX shows a net selling bias of $6.25M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Van Kirk Richard Lee Jr (CEO), who traded 19.2K shares valued at $1.17M on Sep 9, 2026.

Live Market News & Developments
Aggregated real-time headlines for PDEX (PDEX)
6 updates

ProDex (PDEX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Yahoo Finance3h ago

PDEX - Pro-Dex Inc Stock Price and Quote

Finviz177d ago

New Analyst Forecast: $PDEX Given $80 Price Target

Quiver Quantitative4d ago

Pro-Dex, Inc. (PDEX) Q1 Earnings and Revenues Surpass Estimates

Yahoo Finance22d ago

Pro-Dex (PDEX) Stock Rally Masks One Off Boost To Earnings

Simply Wall St76d ago

Pro-Dex: Still A Buy, But Don’t Chase (NASDAQ:PDEX)

Seeking Alpha189d ago

FAQs About PDEX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for PDEX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for PDEX is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 21 sales by company executives over the last 90 days.

The CEO Conviction Index for PDEX is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.